Advanced Genomics Trends Will Unlock Precision Medicine
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
05 Aug 25
Updated
09 Aug 25
AnalystHighTarget's Fair Value
US$18.00
20.6% undervalued intrinsic discount09 Aug
US$14.30
1Y
-39.1%7D
7.0%